Recent studies suggest that targeting CTSS may improve several symptoms of pulmonary diseases, such as mucus production, inflammation responses and lung function as observed in animal models of CF [73] and COPD [58, 99]. The gene discussed is CTSS; the disease is chronic obstructive pulmonary disease.